You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201881 - 201890 of 207714 results
  1. Selectin targeted ultrasound contrast agents for detection of acute coronary synd

    SBC: TARGESON, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Acute coronary syndrome (ACS) accounts for an increasing level of healthcare expense, although patient morbidity and mortality remain relatively high. Current methods for assessing the extent of cardiac ischemic injuryin an acute setting offer limited sensitivity and specificity, which leads to both under- and over-treatment of patients with suspected ACS. In ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Hypertonic Saline for Cystic Fibrosis

    SBC: Parion Sciences, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is an autosomal lethal disease characterized that affects ~30,000 individuals in the US. CF lung disease, the major cause of mortality in CF, is caused by dehydration of airway secretions that leads to mucous adhesion, infection and airways inflammation. A simple means to restore hydration and mucous clearance in CF airways is the inhalati ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. AC5 inhibitor for heart failure

    SBC: VASADE BIOSCIENCES, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Cardiovascular disease is a critical health issue in the US and Western countries. The leading cause of death is heart failure (HF). Almost 5.5 million patients are diagnosed with congestive HF in the U.S and the majorcause of HF is myocardial ischemic disease. Therefore, improvement of therapy for post myocardial infarction (post-MI) HF is extremely important, ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. COPing with Shift Work

    SBC: ISA ASSOCIATES INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Law enforcement officers frequently suffer from excessive fatigue, sleep disturbances, and other health problems associated with shift work and long working hours. The literature on tired officers is unequivocal: fatigued officers use more sick-leave, engage in the inappropriate use of force more frequently, experience more motor vehicle accidents and accidenta ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a Miniature Right Heart Support Device

    SBC: Vadovations, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is one of the most serious medical challenges of our day. With 5 million Americans compromised by the ravages of this disabling disease, CHF is the leading cause of Medicare hospital admissions. The economic burden exceeds 40 billion annually. A comprehensive approach to this ominous healthcare threat includes prevention and earl ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Novel Manufacturing Processes for Tissue Engineered Vascular Grafts

    SBC: HUMACYTE, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): This Phase IIB SBIR application is responsive to NHLBI RFA HL-13-016, NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood and Sleep Disorders and Diseases (R44) . This RFA solicits work on basic, applied, and clinical research on all product and service development related to the mission of the NHLBI. ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Interoperable decision support to improve diagnostic workflow across multiple EHR

    SBC: SimulConsult, Inc.            Topic: NLM

    DESCRIPTION (provided by applicant): This proposal builds on the foundation of the Phase 1 SBIR work that demonstrated that diagnostic decision support software (DDSS) can improve accuracy of diagnosis and efficiency of workup. Phase 2, described here, brings these capabilities more into the clinical workflow through interoperability across multiple Electronic Health Records (EHRs). This will be d ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. PDE4B Inhibitors For Treating Major Depression

    SBC: Tetra Discovery Partners, Inc.            Topic: NIMH

    DESCRIPTION (provided by applicant): Tetra Discovery Partners proposes to develop a new treatment for major depressive disorder based on inhibition of phosphodiesterase 4B (PDE4B). Uniquely, the Tetra drug will address inflammation as a contributor to depression. This is a new mechanism of action for an antidepressant drug which should prove complimentary to current therapeutics. Addressing inflam ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Inhibition of HIV-Induced Synaptodentritic Damage

    SBC: CALIFIA BIO, INC.            Topic: NIMH

    DESCRIPTION (provided by applicant): Combination antiretroviral therapy (cART) has slowed the onset, but has not altered the prevalence of HIV-associated neurologic disease (HAND). In aging patient populations, the prevalence of HAND is increasing, despitethe ability of cART to reduce viral load in the CNS to undetectable levels. Half of the population living with HIV may experience symptoms of HA ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Computer-based HIV Prevention for Seropositive Men

    SBC: ISA ASSOCIATES INC            Topic: NIMH

    DESCRIPTION (provided by applicant): Sexual transmission is the predominant route of HIV infection in the United States, and it is men who are primarily spreading the virus. Male-to-male sexual contact accounts for 72% of all new HIV infections in men while heterosexual contact accounts for 83% of all new HIV infections in women. Extrapolating this incidence data reveals that 75% of all new HIV ca ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government